img

Global Sepsis Diagnostics Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 411 | Industry : Medical Care

Publisher : GRD Survey | Format : PDF

Global Sepsis Diagnostics Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Sepsis Diagnostics market is estimated at 370 million US$ in 2021 and is expected to 560 million US$ by the end of 2028, growing at a CAGR of 5.9% in the forecast period from 2022 to 2028.

This report studies the Sepsis Diagnostics market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (Million USD) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with revenue, market share and growth Rate of Sepsis Diagnostics in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
Microfluidics
Biomarkers

Market Snapshot, By Application
Hospitals
Pathology & Reference Laboratories

Main Market Players Analyzed in this report, including
Thermo Fisher
T2 Biosystems
Roche
Response Biomedical
Mitsubishi Chemical
Luminex
Immunexpress
EKF Diagnostics
Danaher
Cytosorbents
Bruker
Biomerieux
Becton, Dickinson
Axis-Shield Diagnostics
Abbott

The study objectives of this report are
To study and analyze the global Sepsis Diagnostics market size (Million USD) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Sepsis Diagnostics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Sepsis Diagnostics manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Sepsis Diagnostics market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Sepsis Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Sepsis Diagnostics are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Global Sepsis Diagnostics Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028.pdf

List of Figure

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Sepsis Diagnostics Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Sepsis Diagnostics Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Sepsis Diagnostics

3 3 Industrial Lift Cycle and Main Buyers Analysis
3.1 Industry Life Cycle Analysis
3.2 Key Buying Industries/Consumers
3.2.1 Major Buyers in Hospitals
3.2.2 Major Buyers in Pathology & Reference Laboratories

4 Market Segment: by Type
4.1 Sepsis Diagnostics Type Introduction
4.1.1 Microbiology
4.1.2 Molecular Diagnostics
4.1.3 Immunoassays
4.1.4 Flow Cytometry
4.1.5 Microfluidics
4.1.6 Biomarkers
4.2 Global Sepsis Diagnostics Revenue by Type 2016-2021

5 Market Segment: by Application
5.1 Sepsis Diagnostics Type Introduction
5.1.1 Hospitals
5.1.2 Pathology & Reference Laboratories
5.2 Global Sepsis Diagnostics Revenue by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Sepsis Diagnostics Market by Region
6.2 North America Sepsis Diagnostics Market 2016-2021
6.3 Europe Sepsis Diagnostics Market 2016-2021
6.4 Asia Pacific Sepsis Diagnostics Market 2016-2021
6.5 South America Sepsis Diagnostics Market 2016-2021
6.6 Middle East and Africa Sepsis Diagnostics Market 2016-2021

7 North America
7.1 North America Sepsis Diagnostics Market by Country 2016-2021
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Sepsis Diagnostics Market by Country 2016-2021
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Sepsis Diagnostics Market by Country 2016-2021
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Sepsis Diagnostics Market by Country 2016-2021
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Sepsis Diagnostics Market by Country 2016-2021
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Thermo Fisher
12.1.1 Thermo Fisher Company Information
12.1.2 Thermo Fisher Sepsis Diagnostics Product Portfolio, Specification and Application
12.1.3 Thermo Fisher Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.1.4 Thermo Fisher Key Development
12.2 T2 Biosystems
12.2.1 T2 Biosystems Company Information
12.2.2 T2 Biosystems Sepsis Diagnostics Product Portfolio, Specification and Application
12.2.3 T2 Biosystems Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.2.4 T2 Biosystems Key Development
12.3 Roche
12.3.1 Roche Company Information
12.3.2 Roche Sepsis Diagnostics Product Portfolio, Specification and Application
12.3.3 Roche Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.3.4 Roche Key Development
12.4 Response Biomedical
12.4.1 Response Biomedical Company Information
12.4.2 Response Biomedical Sepsis Diagnostics Product Portfolio, Specification and Application
12.4.3 Response Biomedical Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.4.4 Response Biomedical Key Development
12.5 Mitsubishi Chemical
12.5.1 Mitsubishi Chemical Company Information
12.5.2 Mitsubishi Chemical Sepsis Diagnostics Product Portfolio, Specification and Application
12.5.3 Mitsubishi Chemical Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.5.4 Mitsubishi Chemical Key Development
12.6 Luminex
12.6.1 Luminex Company Information
12.6.2 Luminex Sepsis Diagnostics Product Portfolio, Specification and Application
12.6.3 Luminex Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.6.4 Luminex Key Development
12.7 Immunexpress
12.7.1 Immunexpress Company Information
12.7.2 Immunexpress Sepsis Diagnostics Product Portfolio, Specification and Application
12.7.3 Immunexpress Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.7.4 Luminex Key Development
12.9 Danaher
12.9.1 Danaher Company Information
12.9.2 Danaher Sepsis Diagnostics Product Portfolio, Specification and Application
12.9.3 Danaher Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.9.4 Danaher Key Development
12.8 EKF Diagnostics
12.8.1 EKF Diagnostics Company Information
12.8.2 EKF Diagnostics Sepsis Diagnostics Product Portfolio, Specification and Application
12.8.3 EKF Diagnostics Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.8.4 EKF Diagnostics Key Development
12.11 Bruker
12.11.1 Bruker Company Information
12.11.2 Bruker Sepsis Diagnostics Product Portfolio, Specification and Application
12.11.3 Bruker Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.11.4 Bruker Key Development
12.12 Biomerieux
12.12.1 Biomerieux Company Information
12.12.2 Biomerieux Sepsis Diagnostics Product Portfolio, Specification and Application
12.12.3 Biomerieux Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.12.4 Biomerieux Key Development
12.13 Becton, Dickinson
12.13.1 Becton, Dickinson Company Information
12.13.2 Becton, Dickinson Sepsis Diagnostics Product Portfolio, Specification and Application
12.13.3 Becton, Dickinson Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.13.4 Becton, Dickinson Key Development
12.14 Axis-Shield Diagnostics
12.14.1 Axis-Shield Diagnostics Company Information
12.14.2 Axis-Shield Diagnostics Sepsis Diagnostics Product Portfolio, Specification and Application
12.14.3 Axis-Shield Diagnostics Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.14.4 Axis-Shield Diagnostics Key Development
12.15 Abbott
12.15.1 Abbott Company Information
12.15.2 Abbott Sepsis Diagnostics Product Portfolio, Specification and Application
12.15.3 Abbott Sepsis Diagnostics Revenue and Gross Margin (2019-2021)
12.15.4 Abbott Key Development

13 Global Sepsis Diagnostics Market Forecast by Region by Type and by Application
13.1 Global Sepsis Diagnostics Revenue Forecast 2022-2027
13.2 Global Sepsis Diagnostics Forecast by Regions
13.3 Global Sepsis Diagnostics Forecast by Type
13.4 Global Sepsis Diagnostics Forecast by Application

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer